I agree...more than Amyvid. But i wonder how does Eli Lilly feel about the purchase? At all satisfied? It's limitations are well known. Then consider GC describing a blood based Alzheimer's diagnostic as the "holygrail" of diagnostics. Just how much would he sell it for then?